Portnoy Law Firm Announces Class Action on Behalf of Semler Scientific, Inc. Investors
LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Semler Scientific, Inc., (“Semler” or the "Company") (NASDAQ: SMLR) investors off a class action on behalf of investors that bought securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/semler-scientific-inc/. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On February 28, 2025, Semler filed its annual report for 2024, in which it disclosed that “there is a risk that [U.S. Department of Justice (‘DOJ’)] will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages.” Semler also disclosed receipt of an initial civil investigative demand from the DOJ in July 2017 regarding Semler’s claims for reimbursement related to its peripheral artery disease QuantaFlo device. Semler further stated that it had participated in settlement discussions with the DOJ in February 2025, which were unsuccessful. On this news, Semler’s stock price fell $4.03 per share, or 9.4%, to close at $38.89 per share on March 3, 2025.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
